Total submissions: 8
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Laboratory for Molecular Medicine, |
RCV000041185 | SCV000064876 | likely benign | not specified | 2012-03-19 | criteria provided, single submitter | clinical testing | c.864+12T>A in intron 8 of NEXN: This variant is not expected to have clinical s ignificance because it is not located within the splice consensus sequence. It h as been identified in 0.2% (13/6568) of European American chromosomes from a bro ad population by the NHLBI Exome Sequencing Project (http://evs.gs.washington.ed u/EVS). |
Gene |
RCV000041185 | SCV000170746 | benign | not specified | 2014-05-22 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV002054805 | SCV002440910 | benign | Dilated cardiomyopathy 1CC; Hypertrophic cardiomyopathy 20 | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Diagnostic Laboratory, |
RCV001529294 | SCV001742499 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Clinical Genetics, |
RCV000041185 | SCV001919527 | benign | not specified | no assertion criteria provided | clinical testing | ||
Genome Diagnostics Laboratory, |
RCV000041185 | SCV001931994 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV000041185 | SCV001969553 | benign | not specified | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004537145 | SCV004718853 | likely benign | NEXN-related disorder | 2022-07-27 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |